FIELD: medicine.
SUBSTANCE: invention relates to a medicinal products with anticoagulant, antithrombotic, anti-inflammatory activities. A medicinal products that has anticoagulant factor IIa inhibitor, antithrombotic and anti-inflammatory activities and contains 5,7-di(thiophen-2-yl)-4,5-dihydro-[1,2,4]triazolo[1,5-a] pyrimidine.
EFFECT: above invention allows to expand the arsenal of medicinal products to prevent thrombosis.
1 cl, 12 dwg, 14 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIMETHYL 7-METHYL-2-n-TOLYL-4-PHENYLPYRROLO[2,1-f] [2,1,4]TRIAZINE-5,6-DICARBOXYLATE WITH ANTICOAGULANT EFFECT | 2022 |
|
RU2790375C1 |
| ANTICOAGULANT DRUG, WHICH IS A SYNTHETIC DIPEPTIDE Ac-Trp-Arg-Pip·HCl, A PHARMACEUTICAL COMPOSITION COMPRISING SAID ANTICOAGULANT DRUG | 2019 |
|
RU2712194C1 |
| AGENT WITH ANTIPLATELET AND ANTICOAGULANT ACTIVITY | 2015 |
|
RU2601407C1 |
| ANTITHROMBOTIC AGENT OF SIBERIAN FIR CELLULOSE | 2014 |
|
RU2571555C1 |
| AGENT EXHIBITING ANTIPLATELET AND ANTICOAGULANT ACTIVITY | 2014 |
|
RU2573379C1 |
| METHOD OF INHIBITING THROMBUS FORMATION AND ACCELERATION OF FIBRINOLYSIS WITH DNA APTAMERS INHIBITING ACTIVITY OF THROMBIN IN EXPERIMENT | 2014 |
|
RU2559545C1 |
| USE OF ICARITIN FOR OBTAINING MEDICINAL PRODUCTS | 2021 |
|
RU2806093C1 |
| AGENT WITH ANTITHROMBOTIC ACTIVITY | 2016 |
|
RU2627435C1 |
| (2S,4S)-4-AMINO-N-(4-FLUOROPHENYL)PYROGLUTAMIC ACID EXHIBITING CEREBROPROTECTIVE, NOOTROPIC, AND ANTITHROMBOTIC ACTION | 2021 |
|
RU2769521C1 |
| AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
